PubRank

Lloyd A Mack

Author PubWeight™ 16.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dramatic innovations in modern surgical subspecialties. Can J Surg 2010 1.40
2 Desmoids: a revelation in biology and treatment. Ann Surg Oncol 2009 0.93
3 Synoptic surgical reporting for breast cancer surgery: an innovation in knowledge translation. Am J Surg 2010 0.93
4 The quality of life trajectory of resected gastric cancer. J Surg Oncol 2011 0.90
5 Local excision of duodenal gastrointestinal stromal tumor. J Surg Oncol 2007 0.89
6 Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: an emerging treatment option for advanced goblet cell tumors of the appendix. Ann Surg Oncol 2014 0.87
7 Systematic review on the efficacy of multimodal treatment of sarcomatosis with cytoreduction and intraperitoneal chemotherapy. Ann Surg Oncol 2010 0.86
8 Bioprosthetic mesh use for the problematic thoracoabdominal wall: outcomes in relation to contamination and infection. Am J Surg 2012 0.85
9 Operative salvage for retroperitoneal nodal recurrence in colorectal cancer: a systematic review. Ann Surg Oncol 2010 0.84
10 Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy. Ann Surg Oncol 2013 0.83
11 Neoadjuvant radiotherapy and reconstruction using autologous vein graft for the treatment of inferior vena cava leiomyosarcoma. J Surg Oncol 2010 0.82
12 Long-term follow-up in the treatment of peritoneal carcinomatosis. Am J Surg 2011 0.80
13 HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy. J Surg Oncol 2012 0.79
14 Appendiceal goblet cell carcinoid and mucinous neoplasms are closely associated tumors: lessons from their coexistence in primary tumors and concurrence in peritoneal dissemination. J Surg Oncol 2013 0.76
15 Cytoreduction and heated intraperitoneal chemotherapy for colorectal cancer: are we excluding patients who may benefit? J Surg Oncol 2014 0.76
16 Phase II study of regional treatment for peritoneal carcinomatosis. Am J Surg 2009 0.76
17 D1 versus D2 lymphadenectomy and volume versus training: ongoing debate in gastric cancer surgery. J Surg Oncol 2006 0.75
18 Assessing synoptic reports for pancreatic resection. J Am Coll Surg 2012 0.75
19 Where does cytoreductive surgery and hyperthermic intraperitoneal chemotherapy fit into the "usual care" of patients with carcinomatosis? J Surg Oncol 2007 0.75
20 A prospective evaluation of venous thromboembolism in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Can J Surg 2009 0.75
21 Setting Performance Standards for Technical and Nontechnical Competence in General Surgery. Ann Surg 2016 0.75
22 The role of surgical intervention in the management of duodenal lymphoma. J Surg Oncol 2009 0.75
23 Quality of life, functional outcomes, and wound complications in patients with soft tissue sarcomas treated with preoperative chemoradiation: a prospective study. Ann Surg Oncol 2015 0.75